Diabetes

Drug labels for canagliflozin and dapagliflozin revised to include acute injury warning.

Drug labels for canagliflozin and dapagliflozin revised to include acute injury warning.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

A natural compound could increase the overall health of patients with diabetes, heart disease, and obesity.

Health-system pharmacists should fill their patients with diabetes in on the benefits of shared medical appointments after hospital discharge.

Katie Traylor, a PGY2 pharmacy resident in ambulatory care and family medicine, outlines the major glucose monitoring counseling points pharmacists can offer to patients prior to discharge.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes the major glucose monitoring counseling points pharmacists should offer to patients prior to discharge.

Pharmacists are the crux of successful care transitions between hospitals and post-acute care facilities.

Stopping hyperglycemia-induced beta cell death could prevent diabetes.

Patients with rheumatoid arthritis taking glucocorticoids in certain doses may have an increased risk of developing diabetes.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes how certain blood glucose monitors are designed to cater to certain health populations.

Treatment nearly doubled the risk of severe hypoglycemia that required medical attention in patients with type 2 diabetes.

This month, able-bodied Muslims around the world are fasting from dawn until dusk in observance of the holy month of Ramadan.

Varying treatments were seen among patients with diabetes, depression, and hypertension.

Metformin found to improve survival in breast cancer and shows promise in endometrial hyperplasia.

Insulin plus metformin was seen to lower the risk of death and major cardiac events in patients with type 2 diabetes.

Approximately 45% of female patients with atrial fibrillation did not receive blood thinning treatment to prevent strokes.

Study finds new technique may improve treatment of diabetes.

Study finds link between marital bliss and greater risk of diabetes development.

Linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets approved for type 2 diabetes.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

The burden of repeated insulin injections is often cited as a factor of resistance to starting traditional insulin products.

The FDA has issued new guidance for the use of the first-line diabetes drug metformin in patients with renal impairment.

The FDA has approved linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets for adults with type 2 diabetes.